In this regard, the combination of basal insulin (BI) and GLP-1 RA has potent glucose lowering actions and is associated with less weight gain and hypoglycemia compared with fully intensified insulin regimens [1], thus representing a valid alternative to multiple daily injections of insulin. This evidence concerns the gene GLP1R and Hypoglycemia.